KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio: 2017-2025

Historic Debt Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to 0.22.

  • Aquestive Therapeutics' Debt Ratio fell 22.05% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88, marking a year-over-year increase of 209.99%. This contributed to the annual value of 0.32 for FY2024, which is 33.11% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Debt Ratio stood at 0.22 for Q3 2025, which was down 40.67% from 0.37 recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Debt Ratio peaked at 1.02 during Q3 2022, and registered a low of 0.22 during Q3 2025.
  • In the last 3 years, Aquestive Therapeutics' Debt Ratio had a median value of 0.33 in 2025 and averaged 0.41.
  • Per our database at Business Quant, Aquestive Therapeutics' Debt Ratio skyrocketed by 64.91% in 2022 and then tumbled by 67.87% in 2024.
  • Aquestive Therapeutics' Debt Ratio (Quarterly) stood at 0.86 in 2021, then increased by 5.73% to 0.91 in 2022, then plummeted by 47.53% to 0.48 in 2023, then plummeted by 33.11% to 0.32 in 2024, then decreased by 22.05% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.37 for Q2 2025, and 0.33 during Q1 2025.